Read + Share
Amedeo Smart
Independent Medical Education
Zhang JT, Wu YL. Combination Chemotherapy Alone Should Be Used in the Treatment of Patients With Stage IV EGFR-Mutant NSCLC Whose Disease Has Progressed on All Available Tyrosine Kinase Inhibitors. J Thorac Oncol 2021;16:1627-1631.PMID: 34561036
Email
LinkedIn
Facebook
Twitter
Privacy Policy